14th ICID - Poster Abstracts - International Society for Infectious ...

More documents

Recommendations

Info

When citing these abstracts please use the following reference: Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number. Please note that the official publication of the International Journal of Infectious Diseases 2010, Volume 14, Supplement 1 is available electronically on http://www.sciencedirect.com Final Abstract Number: 32.020 Session: Travel Medicine and Travel Health Date: Wednesday, March 10, 2010 Time: 12:30-13:30 Room: Poster & Exhibition Area/Ground Level Type: Poster Presentation Characterization of pre-travel consults at a travel medicine clinic in Buenos Aires in 2008: Experience with 1,439 Travelers P. Elmassian 1 , A. Macchi 1 , C. Biscayart 1 , V. Verdaguer 1 , M. P. Della Latta 1 , D. Stamboulian 2 1 Centros Medicos Dr.Stamboulian, Buenos Aires, Argentina, 2 FUNCEI; Clinical Director, Ciudad Autonoma de Buenos Aires, Argentina Background: Travel industry grows steadily even in the middle of economic crisis, high-impact outbreaks or tragic events. The vast majority of travelers, however, do not seek pre-travel advice. To date our center has a large experience in Latin America, since the launch of the Travel Medicine Division in 1993. We have counseled 54,100 travelers. The objective of this study is to describe some aspects of our experience during 2008. Methods: This is a retrospective observational study. A randomized sample of pre-travel consults stratified by month was obtained. Medical records were reviewed. Data collected included age, sex, destinations, trip purpose, length of stay, time to consult before departure and evaluation of malaria chemoprophylaxis. Results: Among the 1,439 travelers included for analysis, 562 (42.4%) were female and 763 (57.5%) male, mean age was 35.3 years (+/-13.8). Main reasons for travel were tourism, 849 (58.3%) and business, 517 (35.4%). Conventional tourism accounted for 433 consults (51%); adventure tourism for 236 (28%) and ecotourism for 180 (21%). Main destinations were: South America, 510 (31,6%); Africa 267 (16,4%); Central America and Caribbean, 176 (11%); Argentina, 145 (9%), Indian Subcontinent, 117 (7,2%). Median length of stay was 16 days. High-risk travel was the most prevalent category 683 (54,2%). The number of vulnerable travelers (HIV, cancer, pregnancy, diabetes) was very low 37(
When citing these abstracts please use the following reference: Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number. Please note that the official publication of the International Journal of Infectious Diseases 2010, Volume 14, Supplement 1 is available electronically on http://www.sciencedirect.com Final Abstract Number: 32.021 Session: Travel Medicine and Travel Health Date: Wednesday, March 10, 2010 Time: 12:30-13:30 Room: Poster & Exhibition Area/Ground Level Type: Poster Presentation Risk assessment of potential anthropozoonotic pathogen transmission from ecotourists to wildlife populations in Borneo M. Muehlenbein 1 , L. A. Martinez 1 , A. Lemke 2 , L. Ambu 3 , S. Nathan 3 , S. Alsisto 3 , R. Sakong 4 1 Indiana University, Bloomington, IN, USA, 2 University of Wisconsin, Milwaukee, WI, USA, 3 Sabah Wildlife Department, Kota Kinabalu, Malaysia, 4 Red Ape Encounters, Sandakan, Malaysia Background: Over half of all human infections are zoonotic in origin. Nonhuman animal populations are also susceptible to human pathogens. Expanding travel and ecotourism are increasing the likelihood of contact between populations of immunologically-naïve animals and potentially infectious travelers. While the benefits of ecotourism appear clear, anthropozoonotic pathogens transmitted from ecotourists could negatively impact wildlife populations. Methods: To better understand potential infection transmission associated with ecotourism travel, we employed the largest survey to date of self-perceived health and vaccination status in ecotourists. Anonymous surveys were randomly obtained from 633 visitors at the Sepilok Orangutan Rehabilitation Centre (Sabah, Malaysia), Asia’s most frequented wildlife tourism destination. The questionnaire recorded demographic information, history of recent travel, recalled recent contact with livestock, domestic and wild animals, recent diagnoses and symptoms of various infections, and recalled current vaccination status for several infectious diseases. Results: Over half of the sample reported being currently vaccinated against tuberculosis, hepatitis A, hepatitis B, polio, and measles. 15% of the sample self-reported at least one of the following current symptoms: cough, sore throat, congestion, fever, diarrhea, and vomiting. Participants with recent animal contact were more likely to report current respiratory symptoms compared to individuals with no such animal contact (aOR 2.4). Likewise, participants with a medical-related occupation were more likely to report current respiratory symptoms compared to participants with non-medical occupations (aOR 2.2). 67.1% of those with medical-related occupations reported not being currently vaccinated for influenza. Conclusion: Ecotourists represent a potentially significant source of anthropozoonotic infections. Like other international travelers, ecotourists are not adequately protected against vaccinepreventable illnesses. We demonstrate that potentially infectious tourists were visiting a wildlife sanctuary, despite significant animal contact prior to arrival (which may have exposed them to other sources of infection), and despite having at least some basic knowledge about infection transmission (i.e., medical-related occupation). We conclude that a significant proportion of ecotourists are uninformed of the risks they pose to nonhuman animal health. It is the combined responsibility of the medical and tourism communities to accurately communicate the risks of zoonotic and anthropozoonotic infections in ways that best support the needs of humans and wildlife alike.
Page 1 and 2:
When citing these abstracts please
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186: When citing these abstracts please
Page 235: When citing these abstracts please
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299:
show all

14th ICID - Poster Abstracts - International Society for Infectious ...

Create successful ePaper yourself

Delete template?

Save as template?